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Azole drugs selectively target fungal sterol biosynthesis and are critical to our antifungal
therapeutic arsenal. However, resistance to this class of drugs, particularly in the major
human mould pathogen Aspergillus fumigatus, is emerging and reaching levels that have
prompted some to suggest that there is a realistic probability that they will be lost for clinical
use. The dominating class of pan-azole resistant isolates is characterized by the presence
of a tandem repeat of at least 34 bases (TR34) within the promoter of cyp51A, the gene
encoding the azole drug target sterol C14-demethylase. Here we demonstrate that the
repeat sequence in TR34 is bound by both the sterol regulatory element binding protein
(SREBP) SrbA, and the CCAAT binding complex (CBC). We show that the CBC acts com-
plementary to SrbA as a negative regulator of ergosterol biosynthesis and show that lack of
CBC activity results in increased sterol levels via transcriptional derepression of multiple
ergosterol biosynthetic genes including those coding for HMG-CoA-synthase, HMG-CoA-
reductase and sterol C14-demethylase. In agreement with these findings, inactivation of the
CBC increased tolerance to different classes of drugs targeting ergosterol biosynthesis
including the azoles, allylamines (terbinafine) and statins (simvastatin). We reveal that a
clinically relevant mutation in HapE (P88L) significantly impairs the binding affinity of the
CBC to its target site. We identify that the mechanism underpinning TR34 driven overex-
pression of cyp51A results from duplication of SrbA but not CBC binding sites and show
that deletion of the 34mer results in lack of cyp51A expression and increased azole suscep-
tibility similar to a cyp51A null mutant. Finally we show that strains lacking a functional CBC
are severely attenuated for pathogenicity in a pulmonary and systemic model of
aspergillosis.
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Author Summary
Aspergillus fumigatus is the most important airborne mould pathogen and allergen world-
wide. Estimates suggest that>3 million people have invasive or chronic infections that
lead to>600,000 deaths every year. Very few drugs are available to treat the various forms
of aspergillosis and we rely predominantly on the azole class of agents which inhibit sterol
biosynthesis. Resistance to the azoles is growing alarmingly, primarily driven by strains
with two principal genetic signatures (TR34/L98H and TR46/Y121F/T289A). In this study
we identify that the transcriptional mechanism governing resistance in this group of iso-
lates is linked to the opposing actions of 2 transcriptional regulators, SrbA and the CBC,
and uncover a role for the CBC in sterol regulation and virulence in A. fumigatus. We pro-
pose targeting SrbA would provide an effective avenue for therapeutic intervention for
resistant strains.
Introduction
Sterols are components of most eukaryotic cell membranes playing key roles in sustaining
membrane integrity and fluidity. The de novo synthesis of sterols by fungi is essential for their
viability and numerous antifungal drugs have been developed that exploit the differences
between enzymes in the sterol biosynthetic pathway of fungal pathogens and their hosts. The
most notable sterol biosynthetic inhibitors are the azoles which are extensively used in crop
protection and have been the cornerstone of systemic antifungal therapy in man for the last 30
years [1].
Triazoles such as voriconazole (VORI), itraconazole (ITRA) or posaconazole (POSA) repre-
sent the main antifungal drug class employed to treat disease caused by Aspergillus spp.
Although in general Aspergillus fumigatus is susceptible to these drugs, resistance is emerging
and reaching levels that have prompted some health centres to move away from the use of
azoles as a sole first line therapeutic, opting instead for high cost combination therapies and/or
less effective agents [2,3,4,5]. Azole drugs act by inhibiting the function of the sterol
C14-demethylase Cyp51, leading to ergosterol depletion and simultaneous accumulation of
toxic sterol compounds [6]. A principal cause of azole resistance in clinical strains of A. fumiga-
tus is modification of the cyp51A gene, one of two genes that encode isoforms of sterol
C14-demethylase in this pathogen. A particular family of pan-azole resistant isolates domi-
nates. Typified by the TR34/L98H modification, but also including TR46/Y121F/T289A and
TR53, they harbor a tandem repeat in the promoter of cyp51A along with a non-synonymous
mutation resulting in one or more amino acid changes in the Cyp51A protein. In the case of
TR34/L98H this is manifest as a duplication of a 34mer within the 5’ non-translated (5’ NTR)
region of cyp51A, combined with a lysine to histidine substitution at position 98 in the protein.
Understanding the mechanisms by which the TR34/L98H family and non-cyp51A type muta-
tions lead to resistance is critical to formulating strategies to both detect and treat resistant
infections.
What drives resistance in the TR34/L98H family is only partially understood. Introduction
of the L98H modification into a hitherto wild-type (wt) isolate of A. fumigatus results in a
modest but significant increase in triazole tolerance. Introduction of the TR34 variant into a
conventional cyp51A promoter results in an approximate doubling of cyp51A gene expression
and an associated increase in tolerance to azoles [7]. Only when these modifications are com-
bined can isolates reach tolerance levels that exceed clinically relevant breakpoints as defined
by EUCAST (European Committee on Antimicrobial Susceptibility Testing) [8]. Although the
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mechanistic basis of L98H driven increase in azole tolerance has been linked to modification of
the tertiary structure of Cyp51A [7], the cause of increased expression resulting from the TR34
promoter variant has not been elucidated.
In mammalian systems, sterol production is transcriptionally regulated by sterol regulatory
element binding proteins (SREBPs). SREBPs belong to the basic helix-loop-helix (bHLH) tran-
scription factors. In their inactive form they are membrane-bound, once activated the regulator
is released and accumulates in the nucleus where it binds to sterol regulatory elements (SREs)
in the promoters of target genes, including sterol C14-demethylase and activates expression
[9,10]. At sterol excess SREBPs remain inactive causing decreased transcript levels of their tar-
gets [10]. The activating role of the SREBPs is facilitated by the action of the CCAAT-binding
complex (CBC) NF-Y which is made up of three subunits NF-YA, NF-YB and NF-YC. The
SREBPs and NF-Y synergistically activate expression of essentially all genes involved in sterol
metabolism [11].
Orthologues to mammalian SREBPs have been found in several fungi including A. fumiga-
tus. The A. fumigatus SREBP homologue, termed SrbA, is a non-redundant transcription factor
which, like its mammalian counterparts, plays a key role in the regulation of sterol biosynthetic
genes, including cyp51A. In keeping with this role, A. fumigatus strains lacking SrbA have
reduced tolerance to the azoles [12,13,14].
Similarly, A. fumigatus has an orthologue of the CBC. As with the mammalian regulator,
the A. fumigatus CBC is a multimeric transcription factor complex comprising three subunits
(HapB/HapC/HapE) and is highly conserved from yeast (Hap2p/Hap3p/Hap5p) to man
(NF-YA/NF-YB/NF-YC) [11,15,16,17,18,19]. A mutation in the HapE subunit (P88L) was
recently identified as the causative modification that led to azole resistance in an A. fumigatus
strain isolated from a patient in the Netherlands [20].
As both SrbA and the CBC have been directly implicated in modified azole tolerance in A.
fumigatus, and their orthologues have positively acting sterol regulatory functions, we sought
to understand the role of the CBC in sterol biosynthesis and both regulators in clinical azole
resistance. Particularly we were interested in uncovering any role of these regulators in TR34
mediated resistance.
Results
The CBC recognises a CGAATmotif within the azole resistance
associated 34 mer in the promoter of cyp51A, a key gene in the sterol
biosynthetic pathway
The A. fumigatus CBC functions as a heterotrimer comprising HapB, HapC and HapE and is
known to interact with the highly abundant consensus motifs CCAAT and CGAAT [21,22]. A
number of potential binding sites are evident within the cyp51A promoter, therefore we sought
to identify if the CBC interacted directly with the promoter of cyp51A using chromatin-immu-
noprecipitation followed by next-generation sequencing (ChIP-seq). To this end, we replaced
the native hapC gene in isolate A1160P+ with a chimeric gfp-construct. The respective strain
expresses C-terminally GFP-tagged HapC protein (hapCGFP, Fig 1A). We sequenced anti-GFP
bound DNA fractions from cell extracts and identified a single region within the promoter
(within 1kb upstream of the translational start site) of cyp51A to which the GFP-CBC was
bound (S1 Table). The sequencing peak identified by ChIP-seq was at position -297 relative to
the translation start placing it at the 3’ end of the 34mer. This result was validated by ChIP-
qPCR by comparing enrichment of the region identified in the ChIP-seq analysis with region
not bound by the CBC in the promoter of actA (Fig 1B). By examining the promoter region
around the ChIP-seq peak, we found the CBC binding motif CGAAT at position -293 to -289
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(Fig 2A). To further analyse the interaction of the CBC to this motif, binding kinetics and affin-
ity were monitored by surface plasmon resonance spectroscopy (SPR) protein-DNA interac-
tion analysis. Kinetic CBC binding responses to a 37-bp cyp51A promoter duplex revealed a
dissociation constant (KD) of 74.4 nM, demonstrating that the CBC effectively recognised the
CGAAT-293 motif within the original 34mer in vitro (Fig 2B, upper panel 2). Importantly,
although the CGAAT sequence is duplicated in TR34 (CGAAT-327), the binding affinity of the
CBC at the duplicated sequence is about 8-fold decreased and consequently not effectively
bound (Fig 2C panel 2).
HapX, a transcriptional regulator associated with adaptation to
environmental iron cues, binds to the promoter of cyp51A
Cyp51A is known to use iron as a catalytic co-factor and the CBC is a known interaction part-
ner of HapX, an iron responsive basic region leucine zipper (bZIP) transcription factor. We
therefore screened the nucleotide sequence downstream the CGAAT-293 motif for potential
HapX binding sites [19,21,24]. We identified a pseudo-palindromic TTACTAA sequence at
Fig 1. The CBC is a direct regulator of ergosterol biosynthetic genes. (A) The hapCGFP strain is phenotypically indistinct from the wt host and
HapCGFP localises to the nucleus. For confocal laser microscopy 104 spores of the respective isolates were grown in liquid AMM at 37°C for 24 h.
DAPI was used to co-stain the nuclei. (B) In vivo binding of the CBC was confirmed by comparing% recovery of DNA (ChIP-qPCR) from
promoters of ergosterol biosynthetic genes (erg7B, erg13B, cyp51A and cyp51B) to an unbound region of the actA promoter (for more details,
see Material and Methods). Samples have been assessed in duplicate. Error bars indicate the standard deviation of respective samples and p-
values were calculated by Student’s T-test (reference: actA):☆, <0.06; *, <0.05; ** <0.01. (C) Highlighted ChIP-seq peaks at promoters of genes
that were validated by ChIP-qPCR. For ChIP experiments liquid cultures were grown for 18 h at 37°C in AMM.
doi:10.1371/journal.ppat.1005775.g001
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position -275 to -269 in the cyp51A promoter that corresponds exactly to the yeast AP-1
(YAP1) bZIP consensus binding site [25]. Employing SPR co-injection analysis we confirmed
that this region of the cyp51A promoter is synergistically bound by the CBC/HapX complex
(Fig 2B panel 4 and 5). Consistent with the fact that the HapX-binding site is not duplicated in
the 34 base tandem repeat, combinatorial CBC/HapX recognition was not detectable on a
DNA duplex that contained the duplicated CGAAT motif (Fig 2C, panel 4 and 5).
Together these data demonstrate that only the wt 34mer of the cyp51A promoter is a direct
target of the CBC and its interaction partner HapX.
The CBC represses cyp51A expression, this repression is liberated in a
HapEP88L mutant
To determine if the CBC is functioning as a repressor, or an activator of cyp51A gene expres-
sion and to assess the role of the HapEP88L mutation we generated CBC gene deletion mutants
of each subunit of the CBC namely, HapB (ΔhapB), HapC (ΔhapC) and HapE (ΔhapE), a strain
expressing HapEP88L (hapEP88L), and a deletion mutant of HapX (ΔhapX) (S2 Table). Disrup-
tion of any of the CBC subunits, HapX or mutation of HapE resulted in increased tolerance to
ITRA, VORI and POSA (Table 1). Additionally, similar to HapEP88L [20] cyp51A expression
Fig 2. The CBC binds to a CGAATmotif within the 34mer of the cyp51A promoter, which is facilitated HapX. This interaction is perturbed by
the HapEP88L modification. (A) Schematic depiction of the cyp51A TR34 promoter region. (B) & (C) To further analyse the in vivo binding site for the
CBC in vitro, real-time SPR analysis was employed. Binding of the mutated CBCP88L (HapB/HapC/HapEP88L) to DNA (panel 1), wt CBC (HapB/HapC/
HapE) to DNA (panel 2), HapX to DNA (panel 3) and HapX to preformed CBC/DNA complexes (panel 4) was monitored. The SPR sensorgrams are
shown from sensor-immobilised 37 base pair DNA dduplexes containing the CGAATmotifs of the respective wt promoter section (cyp51A-293) as well
as the TR34 tandem repeat variant (cyp51A-TR34). Underlined nucleotides are covered upon CBC binding according to the CBC/DNA binary complex
crystal structure [23]. Binding responses of the indicated CBC or HapX concentrations injected in duplicate (black lines) are shown overlaid with the best
fit derived from a 1:1 interaction model including a mass transport term (red lines). Sensorgrams in panel 5 depict the association/dissociation responses
of HapX on preformed CBC/DNA and were generated by CBC response (co-injection of buffer instead of HapX) subtraction from HapX co-injection
responses. Dissociation constants (KD) are given inside the graphs.
doi:10.1371/journal.ppat.1005775.g002
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was increased by about 2-fold in the ΔhapC strain (Fig 3A). This result indicates that the CBC
and HapX act as repressors of cyp51A and that the HapEP88L mutation abolishes this repressing
function. The loss of repressing activity of HapB/HapC/HapEP88L seems to be linked to a
reduction in binding affinity of the mutated CBC to the CGAAT-293 motif as indicated by SPR
analysis (Fig 2B; compare panel 1 to panel 2).
Combined, these results suggest that azole resistance caused by HapEP88L is linked to
impaired CBC DNA-binding function.
The CBC is a repressor of several genes in the ergosterol biosynthetic
pathway
The discrepancy between the increase in expression of cyp51A (c. 2-fold) and azole resistance
(>32-fold) suggested that cyp51A-independent factors may be influencing azole resistance
in CBC deficient strains. This is supported by the fact that a ΔhapCΔcyp51A is more resistant
to the azoles than a single cyp51A null mutant (Table 1). We therefore hypothesised a possi-
ble function of the CBC in the repression of other genes in the ergosterol biosynthetic
pathway.
Interrogation of our ChIP-seq data allowed us to identify CBC binding sites in the pro-
moter regions (< 1.0 kb 5’ NTR) of around half of the ergosterol biosynthetic genes (14 out of
27, S1 Table). We validated the results of the ChIP-seq analysis by ChIP-qPCR for four of the
genes erg13B, erg7B, cyp51A and cyp51B (Fig 1B). To assess if binding of the CBC was affected
by azole treatment, which would mimic cellular sterol depletion, we performed ChIP-qPCR
using A. fumigatus cultures grown in the presence or absence of ITRA. We found enrichment
of the binding regions in both sterol replete (-ITRA) and sterol deplete (+ITRA) conditions
indicating that the CBC is constitutively bound to all four promoters under these conditions
(Fig 1B).
To investigate if binding of the CBC was linked to regulation of gene expression, we moni-
tored expression levels of several genes associated with the ergosterol biosynthetic pathway in
our CBC mutant (ΔhapC). Specifically we monitored genes coding for enzymes of the first and
committed steps in ergosterol biosynthesis, HMG-CoA synthase (paralogs erg13A and erg13B)
and HMG-CoA reductase (paralogs hmg1 and hmg2), the genes encoding the azole drug target
sterol C14-demethylase (paralogs cyp51A and cyp51B) as well as erg7B, that encodes lanosterol
synthase. For four of these genes, erg13A, erg13B, hmg1 and erg7B, expression was significantly
increased by at least 3-fold in ΔhapC when compared to the isogenic host strain (Fig 3A). For
Table 1. Azole sensitivity of strains generated in this study. MIC testing has been carried out using the
EUCAST broth microdilution reference method [26].
MIC (mg/L)
ITRA VORI POSA
Wt 0.5 0.5 0.03–0.06
ΔhapC >16 2 0.5
hapCREC 0.5 0.5 0.06
ΔhapB >16 2 0.5
ΔhapE >16 2 0.5
Δcyp51A 0.13 0.25 0.016
ΔhapCΔcyp51A 0.25 0.5 0.016–0.03
hapEP88L 16 2 0.5
ΔhapX 1 1 0.25
doi:10.1371/journal.ppat.1005775.t001
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cyp51B we detected a modest increase in transcript levels (>1.5 fold). We were unable to detect
expression of hmg2 in either strain due to the very low abundance of the transcript. It is note-
worthy that our ChIP-seq results did not indicate binding of the CBC to the 1.5 kb region
upstream of the erg13A translation start site, suggesting an indirect regulation of this gene by
the CBC.
Based on the idea that increased expression of several ergosterol biosynthetic genes in CBC
mutants might lead to increased activity of the enzymes, we determined MIC levels of ΔhapC
for simvastatin and terbinafine (Fig 3B). These drugs, belonging to the families of statins and
allylamines, are ergosterol biosynthesis inhibitors that inhibit the enzymes HMG-CoA reduc-
tase (Hmg) and squalene epoxidase (Erg1) respectively. Both of these enzymes perform func-
tions upstream of the C14-demethylation carried out by the Cyp51 enzymes (Fig 3C). In
keeping with our hypothesis, ΔhapC displayed a significant increase in tolerance to both of
these drugs.
Taken together, these data illustrate that loss of the CBC leads to upregulation of genes
involved in several steps of ergosterol biosynthesis, and increases the activity of several enzy-
matic steps in this pathway. This results in resistance to ergosterol biosynthesis inhibitors
belonging to the azoles, statins and allylamine drug classes.
Fig 3. hapC deletion leads to derepression of ergosterol biosynthetic genes and confers resistance to non-azole
ergosterol biosynthesis inhibitors. (A) Transcript levels of six ergosterol biosynthetic genes have been monitored in ΔhapC
using RT-qPCR (gpdA was used as reference gene). Strains were grown in AMM for 18h at 37°C, 200 rpm. Results represent the
mean of biological triplicates and error bars illustrate the standard deviation. p-values were calculated by Student’s T-test
(reference: wt): *, <0.05; ** <0.01. (B) MIC levels of simvastatin and terbinafine, both blocking enzymes upstream Cyp51. (C)
Schematic of ergosterol biosynthetic pathway including targets for inhibitors.
doi:10.1371/journal.ppat.1005775.g003
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CBCmutation results in elevated sterol levels
Resistance to simvastatin, terbinafine and azole drugs suggests that CBC mutation leads to
increased activity of the whole ergosterol biosynthetic pathway. To analyse the effect of loss of
CBC function on ergosterol biosynthesis, sterol levels were quantified using GC-MS. To con-
firm the validity of our results we analysed the ergosterol levels in a srbA null mutant (ΔsrbA).
Loss of SrbA function is documented to result in decreased ergosterol levels and increased
C4-methylated sterols (Table 2, columns 6 and 7) [14]. In keeping with this we demonstrated
that ergosterol levels were decreased (Table 2, column 2: 3.13-fold) in ΔsrbA and an accumula-
tion of eburicol (Table 2, column 6:, 2.37-fold) and 4,4-dimethylergosta-8,24(28)-dien-3β-ol
(Table 2, column 7: 11.03-fold) was observed. In line with our expectations, ΔhapC showed a
2.4-fold increase in ergosterol levels (Table 2, column 2). In addition to ergosterol, which con-
stitutes around 90% of the total sterol content in ΔhapC, we found four further sterols to be ele-
vated in this mutant, including the Cyp51 substrate molecules lanosterol (Table 2, column 5:
1.67-fold) and eburicol (Table 2, column 6: 2.09-fold). The Δcyp51AΔhapC isolate displayed
increased levels of ergosterol (Table 2, column 2: 1.59-fold) but also ergosta-5,7,24(28)-trien-
3β-ol (Table 2, column 3: 1.65-fold) and episterol (Table 2, column 4: 2.51-fold). The hapEP88L
strain showed ergosterol levels similar to that of the wt however, ergosta-5,7,24(28)-trien-3β-ol
(Table 2, column 3: 3.57-fold) and episterol (Table 2, column 3: 3.57-fold) were increased in
this mutant indicating that the regulatory defect in this mutant differs somewhat from the null
mutant.
These findings suggest that transcriptional upregulation of ergosterol biosynthetic genes in
ΔhapC leads to increased sterol levels, particularly ergosterol, which is likely to contribute to
resistance to ergosterol biosynthesis inhibitors in CBC mutants.
CBCmutation results in severe growth reduction and attenuated
virulence in a murine model of aspergillosis
The high abundance of CCAAT and CGAAT motifs in eukaryotic promoters suggests that the
expression of a large proportion of protein coding genes might be affected by CBC mutation.
Hence, it seemed likely that CBC defective mutants would have significant phenotypic defects.
We assessed growth of CBC mutants (ΔhapB, ΔhapC, ΔhapE, hapEP88L) on Aspergillusminimal
medium (AMM), RPMI as well as Sabouraud dextrose agar (SAB, rich-nutrient medium). Lack
Table 2. CBCmutants show increased production of sterols. Sterol levels of transcription factor mutants incubated in AMM for 24 h at 37 C, 200 rpm
have been determined by GC-MS. Δcyp51A served as control for the double deletion mutant ΔhapCΔcyp51A. Sterol content has been normalised to that of
wt. Samples were assessed in biological triplicates. p-values were calculated by Student’s T-test (reference: wt): *, <0.05; ** <0.01. TS, total sterols; bold,
>1.5 fold increase.
Sterol content (FOLD)
1 2 3 4 5 6 7 TS
wt 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
ΔhapC 1.08 2.40* 3.99** 4.84* 1.67* 2.09* 0.98 2.36*
hapCREC 0.96 1.01 1.16 1.01 0.90 1.07 0.76 1.00
hapEP88L 0.98 1.04 3.57** 2.36* 0.73 0.77 1.06 1.07
Δcyp51A 0.81 0.90 1.30 1.22 1.16 0.63 1.50 0.91
Δcyp51AΔhapC 1.03 1.59* 1.65* 2.51* 0.70 1.40 0.35 1.54*
ΔsrbA 0.64 0.32 0.00 0.00 0.52 2.37* 11.03* 0.47
1, ergosta-5,7,9(11),22-tetraen-3β-ol; 2, ergosterol; 3, ergosta-5,7,24(28)-trien-3β-ol; 4, episterol; 5, lanosterol; 6, eburicol; 7, 4,4-dimethylergosta-8,24(28)-
dien-3β-ol.
doi:10.1371/journal.ppat.1005775.t002
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of either subunit resulted in significant growth defects on all media with individual deletion
mutants showing identical phenotypes (Fig 4A). The hapEP88L isolate revealed a less dramatic
phenotype compared to hap-deletion mutants. Growth of this isolate, carrying a single amino
acid mutation, was impaired particularly on RPMI.
To assess the requirement of the CBC in infection, we compared the virulence of ΔhapC and
hapCREC with that of the isogenic control strain in systemic and pulmonary murine models of
aspergillosis. The pathogenicity of the isogenic control and hapCREC strains were indistinguish-
able, causing 100% mortality (n = 10) between 9 and 10 days after systemic infection and
between 12 and 14 days after pulmonary infection. Systemic infection by ΔhapC caused no
mortality while in the pulmonary model only one animal succumbed to the infection (Fig 4B).
Tissue burden studies showed a reduced fungal load in animals infected i.v. (n = 10) and i.n.
(n = 8) with ΔhapC in comparison to those challenged with wt and hapCREC (S1 Fig). Pulmo-
nary infection resulted in high fungal burden in all animals challenged with wt and hapCREC
while ΔhapC was cleared in all mice except two. Kidneys from animals inoculated with wt or
Fig 4. The CBC plays a crucial role in the growth of A. fumigatus and is required for pathogenicity in a pulmonary (non-leucopenic)
and systemic (leucopenic) model of aspergillosis. (A) Radial growth of strains was determined under different nutrient supply. Strains
were grown on AMM, RPMI as well as SAB solid medium; (B) Survival of cortisone acetate immunosuppressed OF-1 mice challenged
intranasally with 1x105 CFU/animal of A. fumigatus. P < 0.05 in comparison to wt and hapCREC. PM, pulmonary model; (C) Survival
proportions of cyclophosphamide immunosuppressed OF-1 mice challenged intravenously with 3x104 CFU/animal of A. fumigatus. P < 0.05
in comparison to wt and hapCREC. SM, systemic model.
doi:10.1371/journal.ppat.1005775.g004
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hapCREC showed low viable fungal elements, however no colonies were detected in ΔhapC-
infected mice. With exception of the brain, the systemic infection resulted in high fungal loads
in all tissues after wt and hapCREC inoculation. Animals challenged with ΔhapC showed signifi-
cantly lower CFU/g in all organs except for the liver and brain when compared to those chal-
lenged with wt or hapCREC.
Taken together, these results demonstrate the crucial role of the CBC for A. fumigatus
growth and show that transcriptional circuits mediated by this regulator are critical during
infection of an immunocompromised host.
The positive regulator of transcription SrbA binds to the 34 mer in the
cyp51A promoter
Our analysis of the CBC suggests that it is associated with the 34mer but not directly responsi-
ble for the transcriptional enhancement of cyp51A observed in strains with the TR34 mutation.
This led us to assess if the other known transcriptional regulator of sterol biosynthetic genes,
SrbA, was involved.
In A. fumigatus the sterol regulatory element binding protein SrbA has been described as
direct positive regulator of sterol biosynthesis in general and cyp51A in particular [13,27]. A
previous study identified a motif similar to the reported sterol regulatory element (Sre1) bind-
ing motif of S. pombe upstream of the TR34 site [13]. In an attempt to corroborate the location
of this site, we performed a retrospective analysis of a recent genome-wide ChIP-Seq evaluation
of SrbA binding [27] and identified a sequencing peak summit at position -302 from the
cyp51A coding sequence start site, which in contrast to the previous predicted location of the
binding site, is within the duplicated 34mer. By comparing the 34 bases of TR34 with the SrbA
consensus binding motif [27] we identified two putative SREs (SRE1 and SRE2, Fig 5A). These
SREs are also evident in the overlapping TR46 and TR53 found in other resistant clinical iso-
lates (Fig 5A) [28,29,30].
To test if SrbA directly interacts with the predicted SREs, we assessed binding of recombi-
nant SrbA to DNA-duplexes containing either SRE1, SRE2 or both sites by SPR (Fig 5B). SrbA
showed interaction with both of the predicted binding sites within the 34mer, however affinity
for SRE1 (KD = 22.8 nM) was 12-fold higher than that for SRE2 (KD = 272.6 nM) (Fig 5B; pan-
els 1 and 2 respectively). Employing a DNA duplex containing both SREs we measured a 2-fold
increase in the saturating SrbA response (Rmax value of 197.6) combined with an apparent KD
of 22.0 nM, which does not represent the simple average of the SrbA affinities measured for the
single SREs. In conclusion, we propose cooperative binding of two SrbA homodimers to the 34
mer (Fig 5B; panel 3). Notably, the affinities of SrbA and the CBC to their partially overlapping
binding motifs are at a similar level (74.4 vs. 22.0 nM), indicating that both regulators bind
competitively to the 34mer within the wt cyp51A promoter. By contrast, the 8-fold lower affin-
ity for CBC at the CGAAT motif duplicated in TR34 will favor cooperative SrbA binding to
both of the SREs in the 5´-TR34 region.
This finding suggests that the increased expression of cyp51A in strains harboring TR34,
TR46 or TR53 could be the result of increased SrbA activity as a result of the duplication of its
consensus binding sites and a lack of CBC and accordingly CBC/HapX repression.
The 34 mer is crucial for activation of cyp51A gene expression and azole
resistance
Based on the hypothesis that the 34mer is required for SrbA mediated cyp51A activation and
consequent azole resistance, we generated a cyp51A promoter variant lacking the 34mer
(cyp51AΔ34, S1 Fig). In order to confirm the previous results described by Snelders in 2011 [7]
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and to draw a direct comparison to the cyp51AΔ34 isolate in an isogenic background, we also
generated a strain carrying the tandem repeat TR34 (cyp51ATR34). Deletion of the 34mer
(cyp51AΔ34) led to a>90% reduction in cyp51A expression similar to the srbA deletion mutant
(ΔsrbA) (Fig 6), which is consistent with our hypothesis. A similar result has been observed in
a previous study using a cyp51A promoter based luciferase reporter approach [31]. In addition,
the cyp51AΔ34 isolate displayed a 4-fold reduction in MIC (from 0.50 mg/L to 0.13 mg/L, Fig
6), which mimics the azole susceptibility phenotype of the isogenic cyp51A deletion mutant
(Δcyp51A). MIC levels for the azoles were even lower for ΔsrbA, which is likely a result of lack
of activation of several ergosterol biosynthetic genes in this mutant [12,27].
Taken together, our data demonstrates that cyp51A activation relies on the presence of the
34mer. This region is required for SrbA mediated activation of cyp51A gene expression, hence,
for azole resistance in A. fumigatus.
Discussion
In this study, we report a novel mechanism for the regulation of ergosterol metabolism in A.
fumigatus and highlight the interplay between the transcriptional regulators SrbA and CBC.
Fig 5. SrbA interacts with a transcriptional enhancer within the 34mer. (A) Alignment of TR34, TR46.1, TR46.2 and TR53. The 34mer is
duplicated in all TR variants (adapted from [30]). bold, 34mer; underlined, duplicated sequence. (B) To further analyze the in vivo binding data
described by Chung et al. [27], we measured binding of recombinant SrbA to this section using real-time SPR analysis. The putative binding sites
identified by comparison to the consensus sequence are shown as SRE1 and SRE2. DNA duplexes containing either SRE1, SRE2 or both were
used for SPR analysis. Sensorgrams of 200, 100, 50, 25, 12.5, 6.25, and 3.13 nM SrbA161-267 binding injected in duplicate (black lines) are shown
overlaid with the best fit derived from a 1:1 interaction model including a mass transport term (red lines).
doi:10.1371/journal.ppat.1005775.g005
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We also describe how perturbation of this regulatory mechanism through numerous routes
can induce resistance to the primary class of agent used to treat fungal disease, the triazoles,
which act by inhibiting ergosterol biosynthesis through depleting sterol C14-demethylase
activity.
In A. fumigatus, the sterol regulatory element binding protein SrbA has been shown to be a
positive acting transcriptional regulator of sterol biosynthesis and, aligned with this, has a cru-
cial role in azole tolerance [14]. A recent study revealed that several ergosterol biosynthetic
genes, including those encoding the two paralogs of Cyp51 (Cyp51A and Cyp51B) and Erg25
(Erg25A and Erg25B), are under direct control of SrbA [27], and strains lacking the regulator
have significant reduction in the expression of the aforementioned genes. The role of SREBPs
in activating expression of sterol biosynthesis is highly conserved.
In mammals, two genes encode three distinct isoforms SREBP-1a, SREBP-1c and SREBP-2,
which are involved in positively regulating various aspects of lipid and sterol metabolism [10].
Fig 6. The 34mer is essential for activation of cyp51A gene expression and azole resistance. (A) cyp51A transcript levels in strains lacking
the 34mer (cyp51AΔ34) and strains carrying TR34 (cyp51ATR34) have been measured using RT-qPCR (gpdA was used as reference gene).
Strains for the expression analysis have been grown in AMM for 18h at 37°C, 200 rpm. Samples have been assessed in biological duplicates.
Error bars indicate the standard deviation of respective samples. p-values were calculated by Student’s T-test (reference: cyp51AREC): *, <0.05;
** <0.01; (B) MIC levels of itraconazole (ITRA), voriconazole (VORI) and posaconazole (POSA); (C) Proposed model highlighting the
mechanistic basis of the 34mer associated azole resistance in the promoter of cyp51A. In susceptible isolates (wt) SrbA homodimers bind to
SRE1 and SRE2 thereby activating expression of cyp51A. The CBC competes with SrbA binding to the 34mer. In resistant isolates, carrying the
duplicated 34mer (TR34), both SREs are duplicated whereas only the CGAATmotif located at the 3’ end of the 34mer is effectively bound by the
CBC. Upregulation of cyp51A in resistant isolates expressing mutated hapE (hapEP88L) is caused by decreased binding affinity of the mutated
complex. Hence, CBC-based competition with SrbA is perturbed enhancing binding of SrbA to the 34mer.
doi:10.1371/journal.ppat.1005775.g006
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The activating role of the SREBPs in mammalian cells is facilitated by the action of the
CCAAT-binding complex NF-Y.
The discovery that an amino acid alteration P88L within the HapE subunit of the CBC in A.
fumigatus leads to resistance to all clinically used azole antifungals provided a potential link
between CBC function and ergosterol biosynthesis and suggested the role of the CBC may also
be conserved. Indeed in keeping with a role of the CBC in regulation of ergosterol biosynthesis
we have demonstrated that the CBC binds the promoters of several genes in the pathway
including cyp51A and cyp51B, erg13B and erg7B. Intriguingly, we identified that the CBC binds
within the 34mer in the promoter of cyp51A commonly duplicated in strains that are pan-
azole resistant (TR34 family strains).
If the CBC were a positive regulator of ergosterol biosynthesis this may explain the mecha-
nistic link between regulation of cyp51A and TR34 associated resistance. Our findings however
are contrary to this hypothesis and suggest that the CBC of A. fumigatus is playing the opposite
role to that of the mammalian orthologue and acting as a negative regulator of sterol biosynthe-
sis. Lack of CBC activity (ΔhapC) leads to derepression of genes in the ergosterol biosynthetic
pathway, including genes coding for enzymes of the initial and committed steps of sterol bio-
synthesis, erg13A, erg13B and hmg1, as well as the azole drug target cyp51A and a concomitant
increase in sterol production and tolerance to drugs inhibiting the ergosterol biosynthetic path-
way (azoles, allylamines and statins). Additionally, we have shown that the CBC binds effi-
ciently only to the original CGAAT motif (Fig 2, CGAAT-293) but not to the duplicated version
within TR34 (Fig 2, CGAAT-327). The reason for the differential binding affinities at these two
sites were not investigated further however several lines of evidence point towards the impor-
tance of the bases outside this core motif as being critical. First, the structure of the Aspergillus
nidulans CBC in complex with DNA demonstrated that hydrogen bonds between the phos-
phate groups of the DNA backbone outside the core motif, and the protein main or side chain
atoms of HapC and HapE, significantly stabilise the protein:DNA complex and induce DNA
bending. Second, alignment of the 23 bp cycA promoter sequence from which this structure
was derived with the native and repeat cyp51A promoter sequences revealed different nucleo-
tides at positions at which HapE amino acid residues mediate DNA sequence-independent
interactions with phosphate oxygen atoms (S2 Fig). Finally our SPR data clearly indicate that
an 8-fold lower CBC affinity to the duplicated TR34 CBC site is due to the presence of eight dif-
ferent nucleotides at the 3´end of the motif. Therefore, our working hypothesis is that altered
DNA-bending might be the major cause for the decreased CBC affinity.
We have determined that the azole resistance exhibited by isolates with the HapEP88L
modification is linked to an inability of the modified CBC to bind effectively to its recognition
site in the cyp51A promoter, leading to increased expression. Interestingly, the growth phe-
notype exhibited by a strain with the HapEP88L mutation is less severe than that of the HapE
null, suggesting only a partial loss of function. One could hypothesise two potential mecha-
nisms for this partial phenotype, 1) the modified CBC retains binding capability for all targets
but with reduced efficacy or 2) the modified CBC loses the ability to bind a subset of its tar-
gets. These scenarios are not mutually exclusive and more likely than not, a combination of
both of these factors are responsible. Interestingly, structural analysis of the closely related A.
nidulans CBC indicates that HapE stabilises the protein:DNA complex by binding through
residues immediately adjacent to P88, namely L89 to K94 [23]. These residues are thought to
interact in a DNA sequence-independent manner. Therefore it is likely that the modified
CBC exhibits a general reduction in binding capability across all of its targets, with other fac-
tors such as the strength of binding of the CBC to the remaining sections of its binding site,
or the presence of stabilising protein interaction partners dictating the strength of binding of
the modified CBC.
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Our genome-wide binding data revealed that the CBC interacts with the cyp51A promoter
during sterol depletion as well as repletion. We found this to be true for almost all the ergos-
terol biosynthetic genes tested, which indicates that the complex might constitutively bind to
these targets. This could suggest a simplistic binary regulatory mechanism at the promoters of
sterol regulatory genes with the CBC carrying out a repressing role in the absence of an activa-
tor, e.g. SrbA. The regulation of sterol metabolism is however far more complex. We have dem-
onstrated that the regulatory element HapX also has a role in the regulation of cyp51A and
azole tolerance. As HapX is known to govern the regulation of genes involved in iron acquisi-
tion as well as iron consumption its association with cyp51A, a heme-iron containing enzyme
is logical. We propose that HapX enhances or stabilises binding of the CBC at the cyp51A pro-
moter in iron limiting conditions and by doing so provides a more nuanced way of regulating
ergosterol biosynthesis in environments that are unfavorable for sterol production. It is possi-
ble therefore that further as yet undefined factors will have a role in the regulation of ergosterol
biosynthesis.
Our data suggests a role for the CBC in TR34 family mediated azole resistance as its repress-
ing function is not duplicated effectively in the repeat. This alone however, could not explain
an increase in cyp51A expression observed in TR strains. Our hypothesis was that a positive
regulator must be binding here. We therefore re-evaluated the sequence of the tandem repeat
and identified two sequences that matched the consensus of the positive regulator SrbA and
which were close to a putative binding site highlighted in a recent ChIP-seq study [27]. We
confirmed SrbA interaction to both of these sequences in the 34mer and cooperative binding
at a region on the TR34. This leads to the conclusion that TR34 family driven upregulation of
cyp51A is a result of effective duplication of SrbA binding sites in combination with ineffective
duplication of the CBC site. It is interesting to note that tandem repeats of transcriptional
enhancer elements are known mechanisms of azole resistance in several phytopathogenic
moulds [32]. For example Hamamoto et al. identified a 126-bp tandem repeat in the cyp51 5’
NTR of the plant pathogen Penicillium digitatum, which caused resistance to Cyp51 inhibitors
[33]. Whether resistance in this case is linked to duplication of SREs and/or ineffective duplica-
tion of repressor elements is unclear, however we have identified sequences within this repeat
that resemble the SrbA binding consensus defined in A. fumigatus [27].
In contrast to A. fumigatus and most other eukaryotes, yeasts such as Saccharomyces cerevi-
siae and Candida albicans SREBPs have been replaced by Upc2p, a zinc-finger transcription
factor which positively regulates sterol synthesis in these species [34]. In C. albicans antifungal
azole resistance caused by overexpression of target genes has been extensively studied identify-
ing Upc2p gain-of-function mutations. These types of mutations result in upregulation of the
Cyp51 encoding gene and appear to be frequent in azole resistant C. albicans clinical isolates
[35]. In A. fumigatus similar mutations in SrbA have not been identified so far. However, our
study demonstrates an alternative route to enhance the activity of the positive regulator, SrbA,
through increasing its DNA-binding ratio by duplicating its binding site.
The cause of the growth deficiency in the CBC null mutants is difficult to pinpoint exactly.
The CBC is a global regulator, its consensus site is present in>30% eukaryotic promoters [22].
In A. nidulans and A. fumigatus several iron metabolic genes are known to be under control of
the CBC in complex with HapX [19,24,36]. Additionally the CBC has also been shown to play
a prominent role in the regulation of secondary metabolism, development and oxidative stress
response [37,38]. These roles and probably the involvement of the CBC in many other biologi-
cal processes are likely to be the cause for reduced fitness in the mutants. Although the same
could be said for the role of the CBC in virulence, its interconnection with the transcription fac-
tor HapX is probably more important in this context. HapX mediated transcriptional adapta-
tion to low iron environments has been demonstrated to be crucial for virulence in A.
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fumigatus and other pathogenic fungi such as C. albicans, Cryptococcus neoformans and Fusar-
ium oxysporum [36,39,40,41]. Hence, we consider one major reason of the reduced pathogenic-
ity to be a direct result of inefficient adaptation to low iron in the CBC mutant. It is interesting
to note that despite a clear attenuation in virulence, an azole resistant CBC loss of function
mutant, namely HapEP88L, was the likely cause of death in a chronic granulomatous disease
patient [42].
This work provides novel insight into the molecular basis of sterol regulation and TR34
mediated azole drug resistance in A. fumigatus and suggests that if the binding of SrbA could
be countered one could reverse drug resistance. The direct targeting of transcriptional binding
is fraught with difficulties. Unlike many enzymes transcription factors have large surface areas
for protein-protein and protein-DNA interactions which are difficult to disrupt with a small
molecule. However modulation of these interactions may be possible using oligonucleotide or
peptide therapeutics if these molecules can be effectively delivered into fungal cells [43]. Some,
albeit limited, data suggests that this may be possible, at least in the case of oligonucleotides
[44] and as significant differences exist between human SREBP and SrbA (less than 40%
sequence identity at the DNA binding domain) selective targeting could be achieved. Alterna-
tively, it should be possible to disrupt upstream activators of SrbA, for example the protease
RbdA which was recently linked to SrbA cleavage and activation [45]. It is encouraging that a
number of small molecules that inhibit Upc2-dependent transcriptional signaling in vivo have
been identified in yeast, providing evidence that a similar, unbiased approach may be successful
in A. fumigatus [46].
Materials and Methods
Ethics statement
All animal care procedures were supervised and approved by the Universitat Rovira i Virgili
Animal Welfare and Ethics Committee.
Strains, oligonucleotides and growth conditions
Strains and oligonucleotides used in this study are listed in S2 and S3 Tables. Conidia were
grown on SAB agar plates. For phenotypic analysis, A. fumigatus liquid cultures were grown at
37°C in AMM according to Pontecorvo et al. [47]. AMM included 1% glucose as carbon source
(w/v) and 20 mM ammonium tartrate as nitrogen source. In vitro susceptibility testing of
mutant strains was carried out using the EUCAST broth microdilution reference method [26].
Strains are defined in this manuscript as resistant where their MIC exceeds the relevant break-
point as defined by EUCAST [8].
Generation of hapB, hapC, hapE, srbA, cyp51A deletion mutants and a
strain expressing hapEP88L in the CEA10 derivative A1160 Δku80 pyrG+
(A1160P+)
Coding sequence of hapB, hapC, hapE, srbA and cyp51A was disrupted in A1160P+. The dele-
tion fragments for homologous recombination were generated using the FusionPCR approach
previously described [48]. Around 1 kb of 5’NTR and 1kb 3’ NTR were PCR amplified and
subsequently linked to an antibiotic resistance cassette via PCR Fusion using primers listed in
S3 Table. The P88L causing mutation of HapE was carried out using a similar FusionPCR strat-
egy. hapE coding sequence and 1kb 3’NTR were amplified from wt genomic DNA. The respec-
tive amplicons were linked to a hygromycin resistance conferring cassette via FusionPCR using
a mutation generating forward primer.
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Reconstitution of Δcyp51A, ΔhapC and gfp-tagging of hapC
To complement Δcyp51A and generate strains harboring modified cyp51A promoters, the basic
plasmid pcyp51AREC, comprising a pyrithiamine resistance cassette, was generated. The plas-
mid for the reconstitution of ΔhapC, phapCREC, was generated following the same principle
described for pcyp51AREC. The backbone of the hygromycin resistance cassette carrying plas-
mid pAN7-1 was amplified using primers pAN7-1-hapC-f/pAN7-1-hapC-r. hapC coding
sequence plus 1.3 5’ NTR and 0.7 3’NTR were amplified with primers hapCrec-f/hapCrec-r.
Both fragments were gel-purified and linked via Gibson assembly as described above.
To tag hapC coding sequence at its 3’ end with gfp, phapCREC was PCR amplified using
primers phapC-GFP-FW/phapC-GFP-RV. The gfp encoding gene was amplified employing
primers GFPhapC-FW/GFPhapC-RV using the recently described plasmid pgfpcccA as tem-
plate [49]. Gel-purified fragments were combined using Gibson assembly yielding phapCGFP.
Generation of cyp51A promoter mutants
Mutation of specific DNA sections was carried out according to the PCR based Q5 site-directed
mutagenesis protocol (NEB). pcyp51AREC was used as template DNA. TR34 was introduced
into the promoter region employing primers TR34-FW/TR34-RV. Δ34-FW/Δ34-RV were used
to delete the 34 mer. After amplification of each construct yielding linearized PCR amplicons,
PCR fragments were gel-purified and circularised using the Quick Ligation Kit (NEB). Plas-
mids carrying cyp51A promoter mutations were designated pcyp51ATR34 and pcyp51AΔ34.
Fungal transformation
Generally 2 μg of the deletion constructs or 2 μg of the respective plasmids were used for trans-
formation. Prior to transformation pcyp51AREC and promoter mutated plasmids were linear-
ised using BsrGI, phapCREC and phapCGFP were digested with PmlI (S3 Fig). For
transformation 1M sucrose was supplemented to AMM or SAB. Depending on the resistance
cassette transformed, 0.1 mg/L pyrithiamine (ptrA), 0.2 g/L hygromycin B (hph) or 0.15 g/L
zeocin (ble) were used for selection. AMM was used for pyrithiamine based transformation,
SAB was used for hygromycin B and zeocin selection at pH 6 and pH 8, respectively.
Sterol analysis: Cultivation and extraction of the cells
Liquid cultures for sterol measurements were grown in AMM for 24 h at 37°C, 200 rpm. Myce-
lia were harvested through filtration, shock frozen using liquid nitrogen and freeze-dried. The
lyophilisate was ground and dissolved in 2M NaOH to obtain a suspension of 3.0 mg/mL. The
work-up procedure can be taken fromMüller et al. [50]. The residue was dissolved in 800 μL
MtBE, 100 μL cholesterol solution (calibration standard, 10 μg/L), and 100 μL of silylation
reagent MSTFA/TSIM (9:1) was added. The sample was gently shaken and stored for complete
silylation at room temperature for at least 30 min, before being subjected to GC-IT-MS analysis
[51,52].
Each sample was prepared in triplicate and measured in duplicate.
Sterol analysis: GC-IT-MS
Sterols were analysed as trimethylsilyl (TMS) ethers. The sterol TMS ethers were identified by
mass spectra and relative retention times (RRT) according to Alcazar-Fuoli et al. and Müller
et al. [50,53]. The sterol TMS ether peaks were referred to the TMS ether peak area of the base
peak of cholesterol TMS ether. The base peaks of each sterol TMS ether were taken as a quanti-
fier ions for calculating the peak areas for cholestanem/z 217, cholesterolm/z 368, ergosta-
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5,7,9(11),22-tetraen-3β-ol (1)m/z 251, ergosterol (2)m/z 363, 5,6-dihydroergosterol (3)m/z
343, ergosta-5,7,24(28)-trien-3β-ol (4)m/z 363, episterol (5)m/z 343, lanosterol (6)m/z 393,
eburicol (7)m/z 407, and 4,4-dimethylergosta-8,24(28)-dien-3β-ol (8)m/z 408. The content
for each sterol [μg/mg] was calculated according to Müller and Bracher [52].
Expression analysis
RNA was isolated using TRI Reagent (Sigma). 10 μg extracted total RNA were digested using
RQ1 RNase-Free DNase (Promega) and further purified using the RNeasy Mini Kit (Qiagen).
qPCR was performed in a 7500 Fast Real-Time PCR System (Applied Biosystems) using the
iScript One-Step RT-PCR kit with SYBR Green (Cat# 170–8893)(Bio-Rad). Primers used for
RT-qPCR analysis are listed in S3 Table. Amplification reactions were performed in a final vol-
ume of 25 μL using (1.0μL) 0.4μM forward primer, (1.0μL) 0.4 μM reverse primer, and 5 ng
(5 μL) of total RNA.
Bacterial expression and purification of proteins for SPR analysis
The A. fumigatus CBC consisting of HapB(230–299), HapC(40–137) and HapE(47–164) as
well as HapX(24–158) were produced and purified as described by Gsaller et al. [19]. A HapE
(47–164) subunit carrying the clinically relevant P88L mutation was generated employing a
synthetic gene. The heterotrimeric HapB/HapC/HapEP88L complex was purified to homogene-
ity by subsequent cobalt chelate affinity and size exclusion chromatography (SEC) just as the
wt CBC (S4A Fig). The heterotrimeric status of the HapB/HapC/HapEP88L complex, or in
other words, its stability was proven by analytical SEC coupled light scattering measurements
(S4B Fig). Therefore, an Äkta Explorer system (GE Healthcare) was connected to a miniDawn
TREOS static light scattering (SLS) detector equipped with an internal quasi-elastic light scat-
tering (QELS) system in series with an OPTILab T-rEX differential refractometer (Wyatt).
Absolute molar mass and hydrodynamic radius (Rh) were determined using the ASTRA 6 soft-
ware (Wyatt). The CBC and CBCP88L were chromatographed in 20 mM Tris/HCl, 400 mM
NaCl, 1 mM DTT pH 7.5 using a Superdex 200 Increase 10/300 GL column (GE Healthcare).
The basic region/helix-loop-helix/leucine zipper (bHLHZ) region of A. fumigatus SrbA
(amino acids 161–267) was purified following the procedure described in Linde et al. [54].
Real-time SPR protein-DNA interaction measurements were performed by using protocols
published previously [19,54].
Fluorescence microscopy
Microscopy images were taken on the Leica TCS SP8 inverted confocal microscope (Leica
Microsystems CMS, Mannheim, Germany) using a 63×/1.2 NA objective. Images were cap-
tured with LAS AF V3.3. Images were processed using ImageJ and Adobe Photoshop CS6.
Chromatin immunoprecipitation and ChIP-qPCR analysis
For ChIP-qPCR analysis 1x106 spores/ml of hapCGFP were grown in 50 mL of AMM for 18 h
at 37°C and 200 rpm.
ChIP was performed as previously described by Chung et al. [27] in this work using an
Anti-GFP antibody (A-11122, Life technologies) or an anti-IgG control (ab46540, abcam) on
Dynabeads Protein A magnetic beads (Thermo Fischer Scientific). Immunoprecipitated DNA
was reverse cross-linked, treated with RNase A (Sigma), and then purified using a PCR purifi-
cation kit (QIAGEN). ChIP’d DNA was eluted with 50 μL of elution buffer and 1 μL of the elu-
tion was used for ChIP-qPCR. All ChIP experiments were performed in biological duplicates.
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ChIP-qPCR was carried out in an Applied Biosystems 7500 Fast Real-Time PCR System
(Thermo Fischer Scientific). Amplification reactions were performed in a final volume of 20 μL
using the iTaq Universal SYBR Green Supermix (Bio-Rad) with 0.4 μM forward primer,
0.4 μM reverse primer, and 1 μL of immunoprecipitated DNA. Oligonucleotides used in ChIP-
qPCR are listed in S3 Table. Percent input method was applied to analyse the enrichment of
the promoter region for each gene and the values were calculated according to the Thermo
Fischer Scientific web site (https://www.thermofisher.com/uk/en/home/life-science/
epigenetics-noncoding-rna-research/chromatin-remodeling/chromatin-immunoprecipitation-
chip/chip-analysis.html). ChIP-qPCR experiments were run in triplicates and the results are
presented together with the background signal and standard error.
Virulence study in a murine model of systemic and pulmonary infection
Virulence of wt, ΔhapC and hapCREC was compared in a model of systemic and pulmonary
infection, both developed in four-week old OF-1 male mice (Charles River; Criffa SA, Barce-
lona). For the pulmonary model, groups of 20 animals (10 for survival and 10 for fungal burden
studies) were immunosuppressed with 125 mg/kg of cortisone acetate, given intraperitoneally
(i.p.), administered four days prior infection and then 3 days per week. Animals were anaesthe-
tized by inhalatory sevofluorane and challenged by nasal instillation (i.n) with conidial suspen-
sions of each strain containing 1x105 CFU/animal in a volume of 25 μl. Systemic infection was
performed in groups of 16 animals (8 for survival and 8 for tissue burden studies) by intrave-
nous (i.v.) inoculation into the lateral tail vein of 3x104 CFU/animal of each strain. Five days
after i.v. or i.n. infection, animals included in the tissue burden study were euthanatised by
CO2 anoxia. Liver, lungs, kidneys, spleen and brain from animals challenged i.v. were asepti-
cally removed for CFU determination, while lungs and kidneys were used in the pulmonary
model. Approximately, one half of each organ was weighted and mechanically homogenized in
1 to 1.5 mL of PBS. Homogenates were serially 10-fold diluted and placed onto potato dextrose
agar plates for CFU/g determination.
Supporting Information
S1 Fig. Effects of hapC deletion on fungal load in organs of immunosuppressed mice. (A)
Cortisone acetate immunosuppressed OF-1 mice challenged intranasally with 1x105 CFU/ani-
mal of A. fumigatus. Horizontal bars represent the median. aP< 0.05 vs. wt, bP< 0.05 vs. hap-
CREC; (B) Cyclophosphamide immunosuppressed OF-1 mice challenged intravenously with
3x104 CFU/animal of A. fumigatus. Horizontal bars represents the median. aP< 0.05 vs. wt,
bP< 0.05 vs. hapCREC.
(TIF)
S2 Fig. Alignment of the native (-293) and repeat region (-327TR) of the cyp51A promoter
bound by the CBC with the A. nidulans cycA region whose structure was elucidated in com-
plex with the AnCBC. Yellow highlights indicate bases conserved in all three binding sites,
blue in two of the three. Underlined bases identify those outside the core domain shown to be
linked with the CBC.
(TIF)
S3 Fig. Scheme of site-directed integration of plasmids for cyp51A promoter mutations
and gfp-tagged hapC. (A) cyp51A based plasmids were linearised using BsrGI and transformed
into Δcyp51A. The same transformation procedure was carried out for all plasmids containing
modified cyp51A promoter versions. (B) Site-directed integration of a plasmid harboring
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C-terminally tagged hapC into ΔhapC.
(TIF)
S4 Fig. Characterisation of purified recombinant proteins used in this study. (A)
SDS-PAGE analysis of wt (HapB/HapC/HapE) and mutated CBC (HapB/HapC/HapEP88L) as
well as recombinant HapX(24–158) protein. (B) Analysis of the solution heterotrimeric state of
HapB/C/E and HapB/C/EP88L complexes by analytical size exclusion chromatography coupled
light scattering measurements. The static light scattering (SLS) signals are shown overlaid with
the calculated absolute molar masses across the elution profiles. Determined molar masses
(Mw) and hydrodynamic radii (Rh) are plotted inside the graph. Note that HapB/C/E
P88L elutes
slightly later than HapB/C/E, which fits with a lower Rh value and indicates a more compact
solution structure of the HapB/C/EP88L complex.
(TIF)
S1 Table. ChIP-Seq Peaks from genes coding for enzymes of the ergosterol biosynthetic
pathway. Cultures were grown for 18 h in AMM at 37°C. TSS, putative transcriptional start
site.
(DOCX)
S2 Table. Strains used in this study.
(DOCX)
S3 Table. Oligonucleotides used in this study (5´!3´).
(DOCX)
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